Table 1

Sample characteristics in 2019 and 2020 analysis groups

20192020
Total4345
Median age (years) (range)65.7 (39–84)65.0 (20–90)
Sex (%)–median age (years) (range)M: 28 (65.1)–67.7 (39–84)
F: 15 (34.9)–62.1 (45–74)
M: 28 (62.2)–65.5 (42–88)
F: 17 (37.8)–64.1 (20–90)
Adequate (%) versus inadequate samples (%)42 (97.7) vs 1 (2.3)41 (91.1) vs 4 (8.9)
Platform, n (%)NGS, 32 (76.2)
Idylla, 4 (9.5)
NGS+Tape Station, 3 (7.1)
Tape Station, 2 (4.8%)
RT-PCR, 1 (2.4)
Idylla, 38 (92.7)
NGS, 3 (7.3)
Median TAT (days) (range)7.9 (3–22)5.3 (1–12)
Sample type, n (%)
- subtype, n (%)
Histological, 33 (78.6)
Resection, 24 (72.7)
Biopsy, 9 (27.3)
Cytological, 8 (19.0)
Cell block, 6 (75.0)
Smear 2 (25.0)
Extracted DNA, 1 (2.4)
Histological, 32 (78.0)
Resection, 24 (75.0)
Biopsy, 8 (25.0)
Cytological, 8 (19.5)
Cell block, 8 (100.0)
Extracted DNA, 1 (2.5)
Diagnosis, n (%)Lung ADC, 20 (47.6)
Colon ADC, 18 (42.8)
GIST, 2 (4.8)
Melanoma, 1 (2.4)
Cystic teratoma, 1 (2.4)
Lung ADC, 18 (43.9)
Colon ADC, 15 (36.6)
Melanoma, 5 (12.2)
GIST, 2 (4.9)
Thyroid anaplastic carcinoma, 1 (2.4)
  • ADC, adenocarcinoma; F, female; GIST: gastrointestinal stromal tumour; M: male; n: number; NGS: next-generation sequencing; RT-PCR, real-time PCR; TAT, turnaround time.